Position in MYGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,308,783
-$1,810,372 QoQ
Shares Held
290,841
-42.7% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,047,271,459 across 33 Diagnostics & Research names. MYGN ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,235,720 | $1,098,923,441 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,678,556 | $943,163,819 | |
| 3 | DHR |
Danaher Corp /De/
|
4,021,153 | $762,410,603 | |
| 4 | WAT |
Waters Corp /De/
|
2,168,285 | $645,715,268 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
3,261,778 | $556,263,609 | |
| 6 | GH |
Guardant Health, Inc.
|
4,946,469 | $456,905,334 | |
| 7 | ICLR |
Icon PLC
|
3,878,869 | $429,235,636 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
2,397,252 | $413,525,968 |
All Filings in MYGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,308,783 | 290,841 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,119,155 | 507,180 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,579,962 | 495,154 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,596,852 | 489,050 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $8,129,530 | 916,520 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $10,546,881 | 769,284 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,277,620 | 557,781 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $14,882,611 | 608,447 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,019,120 | 610,653 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $13,463,456 | 703,420 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $12,151,517 | 757,576 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,456,778 | 709,956 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,830,259 | 423,171 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,720,320 | 807,741 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,196,899 | 429,607 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,049,036 | 442,985 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $16,626,757 | 659,792 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,824,754 | 790,752 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $26,033,002 | 806,225 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,421,159 | 765,898 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $29,880,615 | 981,301 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,938,576 | 502,710 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,530,665 | 500,818 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $10,827,192 | 954,779 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,366,300 | 864,172 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||